NCT03338647View on ClinicalTrials.gov

SBRT or TACE for Advanced HCC

PHASE3UnknownINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

DEB

Infusion of DEB or doxorubin/lipiodol through catheter in the hepatic artery

RADIATION

SBRT

High precision radiation therapy to the liver tumor(s)

Trial Locations (1)

122001

RECRUITING

Medanta, Delhi

Sponsors
All Listed Sponsors
collaborator

International Atomic Energy Agency

OTHER_GOV

lead

University of Aarhus

OTHER